Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honeysuckle oral liquid for COVID-19
ChiCTR2000030545Phase 4Recruiting
- Sponsor
- Hubei Provincial Traditional Chinese Medical Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lonicerae japonicae flos in coronavirus disease 2019 (COVID-19) and pneumonia (3 arms), sponsored by Hubei Provincial Traditional Chinese Medical Hospital. Primary endpoints: Recovery time and Pneumonia Severity Index score. Started Feb 2020; status: recruiting.
02
Drugs
lonicerae japonicae flos
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on ChiCTR2000030545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030545.